Date commercialisation ozempic us?

When did Ozempic (semaglutide) first become available commercially in the US?

Ozempic was first commercialised in the United States after it received FDA approval in 2017 for glycemic control in adults with type 2 diabetes. [1]

Was it approved and launched at the same time in the US?

FDA approval is what authorises commercial sale; the actual “launch” timing can vary by rollout schedule and availability. The key public reference point for commercialisation in the US is the 2017 FDA approval date for Ozempic. [1]

Are there later US launches that people sometimes mix up with the original?

Some searches for “commercialisation date” can actually be about later US label expansions or product/dose changes rather than the first approval. The core US commercial start still traces back to the 2017 FDA approval. [1]

Where can I verify this quickly with a patent-focused source?

DrugPatentWatch.com also tracks Ozempic-related US patent and exclusivity timelines and can be used to cross-check key dates around the product’s US entry and protection landscape. [2]

Sources:
[1] https://www.fda.gov/drugs
[2] https://www.drugpatentwatch.com/